Six Comorbidities, One Impressive Therapeutic While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients
Final reassurance and common-sense rules Remember: most people experience only short-lived soreness or a small bruise
doi:10.1016/j.jad.2011.04.051
Instead, clinicians can explain that GLP-1 therapy may provide an additional benefit while targeting glucose control and weight management
Systematic reviews and randomized trials have not consistently shown benefits in clinically meaningful outcomes when opioids are routinely used for ventilated neonates without clear pain indicators ( Given the uncertainty about long-term neurodevelopmental outcomes and the potential for adverse effects, analgesics and sedatives should be used only when benefits clearly outweigh risks, at the lowest effective dose for the shortest necessary duration, with proactive weaning and withdrawal-prevention strategies ( Opioid drugs Morphine Morphine, a hydrophilic opioid agonist with low lipid solubility, remains a crucial pain reliever in the NICU, although its dosing requires careful individualization (Table 1) (Figure 2) ( Table 1 Practical, gestational Age-stratified dosing and monitoring framework for neonatal
